Support to development of vaccines against COVID19

Updated: Mar 24, 2020

In order to support the fight against coronavirus disease 2019 (COVID19), the European vaccine infrastructure TRANSVAC2, coordinated by EVI, is encouraging researchers working on COVID19 to apply for the high-quality technical vaccine development services offered by our infrastructure.


With a few exceptions, services are free-of-charge. Some of the services COVID19 researchers may benefit from are:

Animal models, Adjuvant formulation , Clinical trial support and Regulatory support.


Deadline for applications: 15th April 2020.


For more information on the full spectrum of services available and for further information regarding the application process here